The FDA just changed the rules on peptides effective April 15, 2026. BPC 157, GHK Cu, MOTS C, and TB 500 have been removed from the Category 2 restricted compounding list. Here is what BPC 157 Cellgenic BPC 157 and TB 500: The Ultima The Peptide Effect Apple Podcasts Gray Market Peptides: So Much Hype, So Little Data Discover the shift in how certain peptides can now be legally prescribed and compounded by pharmacies. This change, influenced by Secretary Robert Kennedy's actions within the Department of Health and Human Services, Q&A: Understanding the Pharmaceutical Community's Attention on Peptides Drug Topics